维普中文期刊产品整合服务
48篇 您的检索式:作者名="Gopal AK"
    题名 作者 年代 出处 被引量
1High- dose radioimmunotherapy versus conventional high - dose therapy and autologoushematopoietic stem cell transplantation for relapsed follicular non -Hodgkinlymphoma: a multivariable cohort analysis 显示文摘Gopal AK Gooley TA 2003Blood2003,102,7:1
2Results of a pivotal phaseII study of brentuximab vedotin for patients with relapsed orrefractory Hodgkin's lymphoma 显示文摘Younes A Gopal AK Smith SE 2012J Clin Oncol2012,30,:1
3Results of a pivotal phase Ⅱ study of bnrentuximab vedotin (SGN-35) in patients with re lapsed or refractory Hodgkin lymphoma显示文摘Chen R Gopal AK Smith SE 2010Blood2010,116,21:1
4^131Ⅰ-tositumomab myeloabla- five radioimmanotherapy for non-Hodgkin's lymphoma: radiation dose to the testes显示文摘Hattori N Gopal AK Shields AT 2012Nucl Meal Commun2012,33,12:1
5Results of a pivotal phase IIstudy of brentuximab vedotin for patients with relapsed or refractoryHodgkin's lymphoma显示文摘Younes A Gopal AK Smith SE 2012J Clin Oncol2012,30,18:1
6Synergistic effects of the fenretinide (4-HPR) and anti-CD20 monoclonal antibodies on apoptosis induction of malignant human B cells 显示文摘Shan D Gopal AK Press OW 2001Clin Cancer Res2001,7,8:1
7High-dose radioimmunotherapy versus conventional high-dose therapy and autologoushematopoietic stem cell transplantation for relapsed follicular non-Hodgkinlymphoma: a multivariable cohort analysis显示文摘Gopal AK Gooley TA 2003Blood2003,102,7:1
8High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma显示文摘Gopal AK Rajendran JG Petersdorf SH 2002Blood2002,99,9:1
9High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular nonHodgkin lymphoma: a muhivariable cohort analysis 显示文摘Gopal AK Gooley TA Maloney DG 2003Blood2003,102,7:1
10An open-label phasell study of ibrutinib in patients with refractory follicular lymphoma显示文摘Salles GA Gopal AK Martin P 2013J Clin Oncol2013,31,15:1
11PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma显示文摘Gopal AK Kahl BS de Vos S 2014N Engl J Med2014,370,11:1
1290Y-ibrimmomab tiux- etan, fludarabine, and TBI based nonmyeloablative allogeneic trans- plant conditioning for patients with persistent high-risk B-cell lym- phoma显示文摘Gopal AK Guthrie KA Rajendran J 2011Blood2011,118,4:1
13Rituximab blocks binding of radiolabeled anti-CD20 antibodies (Ab) but not radiolabeled anti-CD45 Ab 显示文摘Gopal AK Press OW Wilbur SM 2008Blood2008,112,3:1
14Results of a pivotal phase Ⅱ study of brentuximab vedotin for patients with relapsed or refractory Hodgkin' s lymphoma 显示文摘Younes A Gopal AK Smith SE 2012J Clin Oncol2012,30,18:1
15CYP3A-mediated drug-drug interaction potential and excretion of brentuximab vedotin, an antibody-drug conjugate, in patients with CD30- positive hematologic malignancies显示文摘Han TH Gopal AK Ramchandren R 2013J Clin Pharmacol2013,53,8:1
16High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma:a multivariable cohort analysis显示文摘 Gooley TA Maloney DG 2003Blood2003,102,7:1
17Endolaser aroundmaeular hole inthe management of associated retinal detachment in highly myopiceyes显示文摘Kwok AK Chen LL Gopal L 2000Retina2000,20,5:1
18Results of a pivotal phase Ⅱ study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma显示文摘Younes A Gopal AK Smith SE 2012J Clin Oncol2012,30,18:1
19Endolaser around macular hole in the treatment of associated retinal detachment in highly myopic eyes显示文摘Kwok AK Chen LL Gopal L 2000Retina2000,20,5:1
20Clinical applications of anti2 CD20 antibodies显示文摘Gopal AK Press OW 1999J Lab Clin Med1999,134,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费